176 related articles for article (PubMed ID: 27021132)
1. [Influence of steroid hormones on the production of two inflammatory markers, IL-12 and nitric oxide, in Behçet's disease].
Ahmedi ML; Belguendouz H; Messaoudene D; Mesbah-Amroun H; Terahi M; Lahlou-Boukoffa OS; Touil-Boukoffa C
J Fr Ophtalmol; 2016 Apr; 39(4):333-40. PubMed ID: 27021132
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory cellular immune response in Behçet's disease.
Kulaber A; Tugal-Tutkun I; Yentür SP; Akman-Demir G; Kaneko F; Gül A; Saruhan-Direskeneli G
Rheumatol Int; 2007 Oct; 27(12):1113-8. PubMed ID: 17549482
[TBL] [Abstract][Full Text] [Related]
3. [Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis].
Guenane H; Hartani D; Chachoua L; Lahlou-Boukoffa OS; Mazari F; Touil-Boukoffa C
J Fr Ophtalmol; 2006 Feb; 29(2):146-52. PubMed ID: 16523155
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo immunomodulatory effect of all-trans-retinoic acid during Behçet's disease: a study in Algerian patients.
Djeraba Z; Boumedine K; Arroul-Lammali A; Otmani F; Belguendouz H; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):78-86. PubMed ID: 24369064
[TBL] [Abstract][Full Text] [Related]
7. In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease.
Ghozali N; Belguendouz H; Messaoudene D; Hadjimi Z; Ihammichene S; Chekaoui A; Benchabane S; Terahi M; Kediha I; Ali Pacha L; Touil-Boukoffa C
Int Immunopharmacol; 2021 Dec; 101(Pt A):108189. PubMed ID: 34601327
[TBL] [Abstract][Full Text] [Related]
8. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
10. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
[TBL] [Abstract][Full Text] [Related]
11. LPS-induced Src family kinases activity mediates IL-10 production through activation of STAT3 in peripheral blood mononuclear cells of patients with Behçet's Disease.
Irtegun Kandemir S; Tekin MA; Bozkurt M; Dagli AZ; Kalkanli-Tas S
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):116-121. PubMed ID: 29096751
[TBL] [Abstract][Full Text] [Related]
12. Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.
Djaballah-Ider F; Djeraba Z; Chemli M; Dammene-Debbihe N; Lounis D; Belguendouz H; Medour Y; Chaib S; Touil-Boukoffa C
Inflammopharmacology; 2018 Jun; 26(3):725-735. PubMed ID: 29600486
[TBL] [Abstract][Full Text] [Related]
13. [Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Behçet and idiopathic uveitis].
Belguendouz H; Messaoudene D; Hartani D; Chachoua L; Ahmedi ML; Lahmar-Belguendouz K; Lahlou-Boukoffa O; Touil-Boukoffa C
J Fr Ophtalmol; 2008 Apr; 31(4):387-95. PubMed ID: 18563038
[TBL] [Abstract][Full Text] [Related]
14. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
Liu X; Yang P; Wang C; Li F; Kijlstra A
Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
[TBL] [Abstract][Full Text] [Related]
16. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro.
Li ZG; Danis VA; Brooks PM
Clin Exp Rheumatol; 1993; 11(2):157-62. PubMed ID: 8508557
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between inflammation, iron metabolism and endothelial function in Behçet's disease.
Oliveira R; Napoleão P; Banha J; Paixão E; Bettencourt A; da Silva BM; Pereira D; Barcelos F; Teixeira A; Patto JV; Viegas-Crespo AM; Costa L
Clin Hemorheol Microcirc; 2014; 56(2):175-85. PubMed ID: 23619201
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis.
Yavuz S; Akdeniz T; Hancer V; Bicakcigil M; Can M; Yanikkaya-Demirel G
Genes Immun; 2016 Sep; 17(6):335-41. PubMed ID: 27467286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
